Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Melcher

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Gene Therapy|April 23, 2004
Induction of cell stress through gene transfer of an engineered heat shock transcription factor enhances tumor immunogenicityM J Gough, A A Melcher, M R Crittenden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptakeS Todryk, A A Melcher, N Hardwick, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 27, 2007
The immune system--is it relevant to cancer development, progression and treatment?R J Prestwich, F Errington, P Hatfield, et al.
Human Gene Therapy|December 31, 1997
A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma modelS A Castleden, H Chong, I Garcia-Ribas, et al.
British Journal of Cancer|December 3, 2011
Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particlesS J Win, D G G McMillan, F Errington-Mais, et al.
Cancer Research|October 5, 2001
Macrophages orchestrate the immune response to tumor cell deathM J Gough, A A Melcher, A Ahmed, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|February 8, 2014
Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other virusesR V Dave, A H S Jebar, V A Jennings, et al.
Gene Therapy|December 15, 2007
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivoC L White, T Menghistu, K R Twigger, et al.
Gene Therapy|March 14, 2009
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunityE J Ilett, R J Prestwich, T Kottke, et al.
British Journal of Cancer|January 14, 2012
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancerG R Simpson, A Horvath, N E Annels, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Gene Therapy|April 23, 2004
Induction of cell stress through gene transfer of an engineered heat shock transcription factor enhances tumor immunogenicityM J Gough, A A Melcher, M R Crittenden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptakeS Todryk, A A Melcher, N Hardwick, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 27, 2007
The immune system--is it relevant to cancer development, progression and treatment?R J Prestwich, F Errington, P Hatfield, et al.
Human Gene Therapy|December 31, 1997
A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma modelS A Castleden, H Chong, I Garcia-Ribas, et al.
British Journal of Cancer|December 3, 2011
Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particlesS J Win, D G G McMillan, F Errington-Mais, et al.
Cancer Research|October 5, 2001
Macrophages orchestrate the immune response to tumor cell deathM J Gough, A A Melcher, A Ahmed, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|February 8, 2014
Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other virusesR V Dave, A H S Jebar, V A Jennings, et al.
Gene Therapy|December 15, 2007
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivoC L White, T Menghistu, K R Twigger, et al.
Gene Therapy|March 14, 2009
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunityE J Ilett, R J Prestwich, T Kottke, et al.
British Journal of Cancer|January 14, 2012
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancerG R Simpson, A Horvath, N E Annels, et al.
Pageof 4